Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty

Angiology

Volumn 48, Issue 5, 1997, Pages 413-422

  Birand, Ahmet ^a   Kudaiberdieva, Gulmira Z ^a   Batyraliev, Talantbek A ^a   Akgul, Ferit ^a   Usal, Ayhan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

TRIMETAZIDINE;

ADULT; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RISK FACTOR; SYMPATHETIC TONE; TRANSLUMINAL CORONARY ANGIOPLASTY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030957232     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800505     Document Type: Article

References (39)

1. Ferrari R, Curello S, Carguani A, et al: Metabolic changes during postischemic reperfusion. J Moll Cell Cardiol 20:119-133, 1988.
2. Hearse DJ: Reperfusion of ischemic myocardium. J Moll Cell Cardiol 9:607-614, 1977.
3. Ferrari R, Ceconi C, Curello S, et al: Intracellular effects of myocardial ischemia and reperfusion: Role of calcium and oxygen. Eur Heart J 7:3-12, 1986.
4. Marban E, Koretsune E, Coretti M, et al: Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation 20 (suppl 4): 17-22, 1989.
5. Bolli R, Zhu WX, Thomby JI, et al: Time-course and determinants of recovery of cardiac function after reversible ischemia in conscious dogs. Am J Physiol 254:H102-114, 1988.
6. Manning AS, Hearse DJ: Reperfusion-induced arrhythmias: Mechanisms and prevention. J Moll Cell Cardiol 16:497-518, 1984.
7. Prasad K, Kalra J, Chan WP, et al: Effect of oxygen free radicals on cardiovascular function at organ and cellular levels. Am Heart J 117:1196-1202, 1989.
8. Zipes DP: Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82:1095-1105, 1990.
9. Lombardi F, Verrier RL, Lown B: Relationship between sympathetic neural activity, coronary dynamics and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J 105:958-965, 1983.
10. Pagani M, Lombardi F, Guzetti S, et al: Power spectral analysis of heart rate and blood pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 59:178-193, 1986.
11. Pomerantz B, Macaulay RJB, Caudill MA, et al: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 248:H151-153, 1985.
12. Vaishnav S, Stevenson R, Marchaut B, et al: Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol 73:653-657, 1994.
13. Bigger JT, Fleiss JL, Stienman RC, et al: Frequencydomain measures of heart period variability and mortality after myocardial infarction. Circulation 85:164-171, 1992.
14. Hayano J, Yamada A, Mukai S, et al: Severity of coronary atherosclerosis correlates with respiratory component of heart rate variability. Am Heart J 121:1070-1079, 1991.
15. Airaksinen KE, Ikaheimo MJ, Huikuri HV, et al: Responses of heart rate variability to coronary occlusion during coronary angioplasty. Am J Cardiol 72: 1026-1030, 1993.
16. Chierchia SL, Fragasso G: Metabolic management of ischemic heart disease. Eur Heart J 14 (suppl G):2-5, 1993.
17. Maridonneau-Parini I, Harpey G: Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol 20:148-151, 1985.
18. Leris J, Boucher F: Rationale for trimetazidine administration in myocardial ischemia-reperfusion syndrome. Eur Heart J 14:34-40, 1993.
19. Sellier P: Effects de la trimetazidine sur les parametres egometriques dans L'angord' effort. Etude multicetrique controlee a double insu contre placebo. Arch Mal Couer 9:1331-1336, 1986.
20. Passeron J: Efficacite' de la trimetazidine dans l'angor d'effort stable del' insuffisant coronarien chronique. Presse Med 35:1775-1778, 1986.
21. Monpere C, Brochier M, Demange J, et al: Combination of trimetazidine with nifedipine in effort angina. Cardiovasc Drugs Ther 4:824-825, 1990.
22. Michaelides AP, Vyssouleis GP, Bonoris PE, et al: Beneficial effects of trimetazidine in men with stable angina under beta-blocker treatment. Curr Ther Res 46:565-576, 1989.
23. Detry JMR, Leclercq P: Trimetazidine European Multicenter study versus propranolol in stable angina pectoris: Contribution of Holter electrocardiographic ambulatory monitoring. Am J Cardiol 76:8B-11B, 1995.
24. Levy S: Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Am J Cardiol 76:12B-16B, 1995.
25. Kober G, Pennaforte S, Buck T, et al: Myocardial cytoprotection during percutaneous transluminal coronary angioplasty. Eur Heart J 14 (suppl G):6-11, 1993.
26. Kaufman ES, Bosner MS, Bigger JT, et al: Effects of digoxin and enalapril on heart period variability and response to headup tilt in normal subjects. Am J Cardiol 72:95-99, 1993.
27. Kennedy JW, Trenholme SE, Kasser IS: Left ventricular volume and mass from single-plane cineangiogram. A comparison of anteroposterior and anterior oblique methods. Am Heart J 80:343-347, 1970.
28. Mehta N, Bennet DE: Impaired left ventricular function in acute myocardial infarction assessed by Doppler measurement of ascending aortic blood velocity and maximum acceleration. Am J Cardiol 57:1052-1058, 1986.
29. Hunt AC, Chow SC, Perry RA, et al: Changes in Doppler indices of cardiac function during and after percutaneous transluminal coronary angioplasty. Br Heart J 66:346-350, 1991.
30. Baselli G, Gerutti S, Civardi S, et al: Heart rate variability signal processing: A quantitative approach as an aid to diagnosis of cardiovascular pathologies. Int J Biomed Computing 20:51-70, 1987.
31. Califf KM, Phillips HR, Hindman MC, et al: Prognostic value of coronary artery jeopardy score. J Am Coll Cardiol 5:1055, 1985.
32. Huikuri HV, Niemela MJ, Ojala S, et al: Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and up-right posture. Circulation 90:121-126, 1994.
33. Holmes DR, Vlietstra R, Reeder G, et al: How cumulative is the risk of restenosis with multilesion dilatation? J Am Coll Cardiol 2:235A, 1988.
34. Airaksinen KEJ, Ikaheimo MJ, Peuhkurinin MJ, et al: Effect of preocclusion stenosis severity on heart rate reactions to coronary occlusion. Am J Cardiol 74:864-868, 1994.
35. Godfried SL, Deckelbaum LI: Natural antioxidants and restenosis after percutaneous transluminal angioplasty. Am Heart J 129:203-210, 1995.
36. Leiris J, Boucher F: Rationale for trimetazidine administration in myocardial ischemia/reperfusion syndrome. Eur Heart J 14 (suppl G):34-40, 1993.
37. Miazaki T, Zipes DP: Presynaptic modulation of efferent sympathetic and vagal neurotransmission in the canine heart by hypoxia, high K*, low pH and adenosine: Possible relevance to ischemia-induced denervation. Circ Res 66:289-301, 1990.
38. Bekheit S, Tangella M, El-Sakr A, et al: Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 119:79-85, 1990.
39. Cook JR, Bigger JT, Kleiger RE, et al: Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 17:480-484, 1991.